We are an interdisciplinary group of scientists and engineers who are developing novel platforms of next generation therapeutics and diagnostics to improve the treatment of human diseases.
Omid Veiseh, Ph.D.Assistant Professor of Bioengineering, CPRIT Scholar in Cancer Research firstname.lastname@example.org
Dr. Omid Veiseh is an Assistant Professor and CPRIT Scholar in Cancer Research in the Department of Bioengineering at Rice University. He received a dual Ph.D. in Materials Science & Engineering and Nanotechnology from the University of Washington. Dr. Veiseh completed his postdoctoral research with Prof. Robert Langer and Prof. Daniel Anderson at MIT and Harvard Medical School. Over the course of his career he has authored, or co-authored more than 50 peer-reviewed publications including those in Nature, Nature Biotechnology, Nature Materials, Nature Medicine, and is an inventor on 20 pending or awarded patents, many of which have been licensed for commercialization by 3 separate biotechnology companies. He is Co-Founder of Sigilon Therapeutics. Throughout his career he has received numerous awards and fellowships including: a $2 million CPRIT Scholar In Cancer Research Award from state of Texas, and was recently named one of MedTech Boston’s 40 Under 40 Healthcare Innovators for 2017.
Dr. Elham Babaie Ph.D.
B.Sc, Biomedical Engineering, Amirkabir University of Technology, 9/2008
M.Sc, Biomedical Engineering, Amirkabir University of Technology, 1/2011
Phd, Biomedical Engineering, University of Toledo, 12/2016
Research Keyword: biomedical engineering, bioengineering, biomaterials, regenerative medicine, orthopedic materials
Bachelors degree: (St. Xavier’s college, Kolkata, India, Degree: B.Sc. (graduate); Chemistry, June 2006-09)
(Ramakrishna Mission Residential College, Narendrapur, India, Degree: M.Sc. (postgraduate); Organic Chemistry, 2009-11)
Ph.D. degree: (CSIR-Indian Institute of Chemical Technology, Hyderabad, India, Degree: Ph.D.; Chemical Science; specialty: Nanomedicine; 2011-17)
Research Keyword: nanomedicine, chemistry, cancer research, molecular imaging